$599
Basal Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics

Madrigal Acquires Oral GLP-1RA; Beta Bionics, Ionis, and Teva Q2 ‘25 Earnings; Tidepool/Abbott Integration 

A series of cardiometabolic-related news items has been observed from Madrigal Pharmaceuticals, Beta Bionics, Tidepool/Abbott, Ionis, and Teva. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here
OR
Return to Home